GSK advances mRNA Influenza vaccine program to late-stage trials
UK—GSK, a British pharmaceutical company, published positive results from a mid-stage trial of its...
Read More
Tag: GSK
GSK’s Asthma drug meets primary goal in Phase III Trial
UK—British drugmaker GSK has announced that its asthma drug, Nucala (mepolizumab), has achieved...
Read More
GSK Singapore secures HSA approval for expanded use of Jemperli in endometrial cancer treatment
SINGAPORE — GSK Singapore has received approval from the Singapore Health Sciences Authority (HSA)...
Read More
GSK, CureVac restructure collaboration into new licensing agreement for mRNA vaccine development
UK — GSK plc and CureVac N.V. have restructured their existing collaboration into a new licensing...
Read More
Abu Dhabi partners GSK to establish regional vaccine distribution hub
UAE – The Department of Health (DoH) in Abu Dhabi has forged a strategic partnership with...
Read More
GSK completes US$1.4 B acquisition of Aiolos Bio
USA – In a significant expansion of GSK’s respiratory biologics portfolio, the company has successfully concluded the acquisition of Aiolos Bio for a deal potentially reaching US$1.4 billion.
Read More
UAE, GSK join forces to advance personalized healthcare
UAE—The Department of Health – Abu Dhabi (DoH) has signed a Memorandum of Understanding...
Read More
GSK sales of RSV vaccine surpass US$1.5B on back of strong demand in US
UK – GlaxoSmithKline (GSK) sold over US$1.5 billion worth of its recently launched...
Read More
GSK’s Nucala secures NMPA approval for severe asthma treatment
CHINA – China’s National Medical Products Administration (NMPA) has approved Nucala (mepolizumab)...
Read More
GSK’s Jemperli secures European approval for advanced endometrial cancer treatment
UNITED KINGDOM — GlaxoSmithKline (GSK) has achieved a significant milestone as the European...
Read More
LATEST DIGITAL MAGAZINE
